Allogeneic CD19 CAR T cells armed with an anti-rejection CD70 CAR overcome antigen escape and evade alloimmune responses.

Saved in:
Bibliographic Details
Title: Allogeneic CD19 CAR T cells armed with an anti-rejection CD70 CAR overcome antigen escape and evade alloimmune responses.
Authors: Zhang K; Allogene Therapeutics Inc., South San Francisco, CA, USA., Li Z; Allogene Therapeutics Inc., South San Francisco, CA, USA., O'Dair MK; Allogene Therapeutics Inc., South San Francisco, CA, USA., Qu D; Allogene Therapeutics Inc., South San Francisco, CA, USA., Mealy AK; Allogene Therapeutics Inc., South San Francisco, CA, USA., Nguyen D; Allogene Therapeutics Inc., South San Francisco, CA, USA., Cheng HY; Allogene Therapeutics Inc., South San Francisco, CA, USA., Huang D; Allogene Therapeutics Inc., South San Francisco, CA, USA., Gopalakrishnan S; Allogene Therapeutics Inc., South San Francisco, CA, USA., Roberts ZJ; Allogene Therapeutics Inc., South San Francisco, CA, USA., Sommer C; Allogene Therapeutics Inc., South San Francisco, CA, USA. cesar.sommer@allogene.com., Lauron EJ; Allogene Therapeutics Inc., South San Francisco, CA, USA. elvin.lauron@allogene.com.
Source: Nature communications [Nat Commun] 2026 Apr 12; Vol. 17 (1). Date of Electronic Publication: 2026 Apr 12.
Publication Type: Journal Article
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first